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Abstract. The regulation of secretion of chorionic gonadotropin in primates has been studied 
using both in vivo and in vitro models. In vivo studies using the pregnant bonnet monkey 
revealed that at the doses tested, the administration of progesterone or estradiol 17β in 
combination or alone did not result in any appreciable change in the duration or magnitude of 
serum chorionic gonadotropin levels. However, administration of lutropin-releasing hormone 
by intravenous route resulted in significant increase in chorionic gonadotropin levels within 
30–60 min and the extent of stimulation seemed to depend on the state of pregnancy. For in
vitro studies, explants or cells prepared from first trimester human placenta has been used. The 
functional integrity of these cells has been established by demonstrating the binding of [125I]- 
labelled human chorionic gonadotropin antibody to the cells as well as the synthesis of [3H]-
labelled human chorionic gonadotropin. In vitro studies using the cells revealed that addition 
of lutropin-releasing hormone caused a significant increase in chorionic gonadotropin and 
estradiol 17 β secreted into the medium. Thus both in vivo and in vitro results suggest that 
lutropin-releasing hormone could be one of the factors involved in regulation of chorionic 
gonadotropin secretion in primates.
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Introduction 
 
The placenta in addition to serving the function of transport of metabolites between the 
maternal and foetal system, also serves as an endocrine gland, by elaborating both 
protein, peptide and steroid hormones. Of the protein hormones elaborated by primate 
placenta, chorionic gonadotropin (CG) has been extensively studied, particularly in the 
case of the human. Available evidence indicates that the primary functions of CG is to 
extend the life span of the corpus luteum of fertile cycle and maintain its steroidogenic 
activity. In all the primates studied thus far, the appearance of CG is generally 
associated with implantation (Hendrickx and Enders, 1980). Serum concentration of 
CG reach maximal values during early pregnancy and it declines rapidly thereafter, 
either becoming undetectable as in macaques or maintained at low levels as in human 
females and a few other non-human primates (Tullner, 1974). Although considerable 
information has accrued over the years on the chemistry and physiology of CG, very
 
 
Abbreviations used: CG, Chorionic gonadotropin; hCG, human chorionic gonadotropin; LH, luteinizing 
hormone or lutropin; LHRH, lutropin-releasing hormone; mCG, monkey CG; NBMCS, new born male calf 
serum; MTP, medical termination of pregnancy; KRBG, Kreb’s bicarbonate glucose.
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little is known about the factors or mechanism involved in the initiation of CG 
production, as well as the means by which its continuous production is either shut off or 
substantially reduced. The present report essentially provides a brief summary of the 
studies initiated recently to examine the regulation of CG using both in vivo and in vitro 
approaches. 
 
 
 
Materials and methods 
 
Monkeys 
 
For in vivo studies, the south Indian bonnet monkey has been used. The details of 
husbandry, maintenance and breeding has been described in earlier communications 
(Prahlada et al., 1975; Rao et al, 1984).
 
Chemicals
 
All unlabelled steroids were obtained from Steroloids, New Hampshire, USA. Tritiated
leucine (specific activity, 130–190 Ci/mmol), thymidine (specific activity,
70–90 Ci/mmol), progesterone (specific activity, 100–130 Ci/mmol), estradiol 17β 
(specific activity, 140–170 Ci/mmol) and [125I]-were obtained from Amersham
International, UK. Unlabelled thymidine, leucine and DNA were obtained from Sigma 
Chemicals Co., St. Louis, Missouri, USA, collagenase from Worthington and Co., 
Freehold, New Jersey, USA, human chorionic gonadotropin (hCG) (CR 123) and 
lutropin-releasing hormone (LHRH) were gifts from NIH, Bethesda, Maryland, USA.
Ovine luteinizing hormone (LH) and LHβ were kindly provided by Dr. M. R. Sairam, 
Clinical Research Institute of Montreal, Montreal, Canada and Dr. C. H. Li, Hormone 
Research Laboratory, University of California, San Francisco, USA. Tissue culture 
media were obtained from Himedia, Bombay and disposable culture were from Falcon
Plastics, USA. New born male calf serum (NBMCS) was obtained locally and a pooled 
large batch was sterilised and used in all studies.
 
Analytical techniques
 
Analysis of monkey CG (mCG), progesterone, estradiol 17β, were done according to
the procedures validated in the laboratory (Rao et al., 1984). Iodination of hCG was 
done according to the Chloramine Τ method of Greenwood et al. (1963). For 
quantitation of hCG in human placental culture samples, radioimmunoassay using 
rabbit anti-sera to hCG (1:40,000) and [125I]-hCG was employed. The assay
sensitivity was 0·l ng/ml and intra and inter-assay variations were 6·2% and 10·1%
respectively. 
 
Experimental procedures with monkeys 
 
All injections were given at 10·00 h unless otherwise specified. Blood samples were 
collected from saphenous vein without using anaesthesia, serum was separated within 6
to 8h and stored at –20°C until further processing.
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Isolation of cells from human placenta
 
First trimester human placenta (before 10 weeks of pregnancy) was collected from cases 
of medical termination of pregnancy (MTP) from local hospital. The tissue suspended 
in Kreb’s Ringer bicarbonate glucose (1 mg/ml) (KRBG), pH = 7·2, was quickly
transported on ice to the laboratory, washed extensively with cold KRBG to remove 
blood clots and villi were separated out by visual examination. The villi were minced 
with fine scissors and digested with collagenase (0·1 mg/ml) in KRBG for 10–15 min at
37°C with gentle shaking. After digestion, the tissue suspension was diluted with 
KRBG and dispersed by drawing it in and out of a sterile plastic syringe connected with 
a tygon tubing and allowed to settle by standing. Supernatant was carefully removed 
and filtered through a 100 µ nylon mesh and the process repeated several times till no 
tissue remained. Pooled filtrate was centrifuged at 500 g at room temperature, pellet 
was washed once with KRBG and resuspended in minimal volume of Ham F-10 
medium containing antibiotics (Penicillin 100 units/ml, Streptopenicillin 100 µg/ml, 
Gentosporin 50 µg/ml) and 20% NBMCS. For short term in vitro studies, cells (1 × 106
cells/tube in 0·5 ml) were incubated with 1 µCi tritiated leucine or thymidine for 4 h at
37°C in KRBG under 95% oxygen and 5% carbon dioxide and processed for 
incorporation of label into protein and DNA according to procedures standardised in 
this laboratory (Sheela Rani and Moudgal, 1977). hCG in the incubation medium was 
precipitated using a highly potent antisera to hCG in goats.
 
Cell culture 
 
For culture, 5 × 106 cells in 5 ml of Ham F-10 medium were plated in Falcon petri 
dishes and maintained under sterile conditions in Forma Water Jacketted Incubator 
with 5 % carbon dioxide at 37°C. Medium (containing 10 % NBMCS and antibiotics) 
was changed every 24 h and hCG, progesterone and estradiol 17 β in the medium were 
analysed by radioimmunoassay. For demonstration of [125I]-labelled hCG antibody 
binding to cultured cells, cells were fixed with methanol, acetic acid (3:1) and incubated 
with [125I]-labelled antibody in the presence or absence of excess unlabelled goat 
gamma globulin. [125I]-was monitored in a PRlA’s Packard Counter and β-counting 
was done in an LKB counter. Statistical analysis was done using Student’s ‘t’ test.
 
 
Results 
 
In vivo studies in the pregnant bonnet monkey
 
Effect of administration of gonadal steroids on the pattern of CG secretion during early 
pregnancy in Macaca radiata: It is well known that pituitary gonadotropin secretion is 
controlled via feed back regulation by gonadal steroids. As the placenta produces both 
gonadotropins and steroid hormones (CG somatomammotropin, progesterone, 
estradiol 17 β and others), it was considered of interest to examine whether the 
administration of gonadal steroids has any effect on serum CG levels. The experimental 
design consisted of confirming pregnancy by monitoring CG levels on day 28 of fertile 
cycle, and injecting progesterone and estradiol 17 β thereafter according to protocol, 
described below. Our earlier studies (Rao et al., 1984) have shown that CG is detectable
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by about day 28 of fertile cycle, and that it rapidly reaches peak values by day 35–37
declining thereafter to undetectable levels beyond days 50–55 of fertile cycle. Since the 
mid-cycle estrogen and LH surges occur in these monkeys on days 8–9 and 10–11 of
cycle respectively (Rama Sharma et al., 1978) and the females are mated with breeder 
males between days 9–14 of cycle. We have considered here day 12 of fertile cycle as day
1 of pregnancy. After confirming pregnancy, the monkeys were injected at 10.00 h i.m. 
1 mg of progesterone or 10 µg of estradiol 17 β or a combination of both in 0·5 ml of 
groundnut oil per monkey per day from day 30 to day 40 of fertile cycle. Blood samples 
were collected from day 30 to 60 of fertile cycle and serum CG was determined by 
radioimmunoassay. The results obtained in the experiment where a combination of 
progesterone (1 mg) and estradiol 17β (10 µg) was administered is presented in figure 1.
 
 
Figure 1. Effect of administration of progesterone (1 mg) and estradiol 17 β (10 µg) every 
day from day 30 to 40 of fertile cycle on serum CG levels in pregnant bonnet monkey. 
A. Depicts the normal profile of CG in four pregnant monkeys. B. Depicts the profile
following administration of progesterone and estradiol 17 β in another set of three monkeys.
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No significant change in the pattern or magnitude of CG levels (figure 1B) during the
period under study could be seen when compared with the normal profiles (figure 1A). 
Essentially similar results were obtained even where each of the steroid hormones were 
injected separately. The present dose was selected taking into consideration the average  
early pregnancy in the bonnet monkey. It appears necessary that more studies have to 
be carried out by injecting different quantities of progesterone and estradiol 17 β before 
a definitive conclusion can be reached.
 
Effect of LHRH administration on serum levels of CG during early pregnancy: The role 
of LHRH in modulating pituitary gonadotropin secretion is well documented, using a 
variety of experimental animals. Recent studies have provided evidence that LHRH like 
material is present in the human placenta (Siler-Khodr and Khodr, 1978). It has also 
been shown that it is biosynthesised in the placenta (Khodr and Siler-Khodr, 1980) and 
that addition of LHRH to cultures of human placenta results in an increase in CG 
released into the medium (Siler-Khodr and Khodr, 1981). In view of this it was 
considered worthwhile examining the effects of LHRH administration in an in vivo 
model. Two different regimens of LHRH were used. The first one consisted of 
administering a small dose (10 µg) of LHRH by i.m. route in 0·2% gelatin every day 
from day 30 to day 36 of fertile cycle and analysing daily serum samples for CG. The 
other approach consisted of giving a bolus of 100 µg of LHRH by i.v. route on different 
days of fertile cycle and analysing blood samples collected at close time intervals for 
serum CG. The results of these studies are presented in table 1 and figure 2. It can be 
seen that administration of a low dose of LHRH chronically had no effect on serum CG 
levels (table 1) as judged by the levels on day 37 of fertile cycle (normally CG levels 
reach maximal values by this day). However, use of a large dose of LHRH resulted in a 2 
to 3 fold increase in serum CG levels within 30–45 min (figure 2). Even here, stimulation 
was restricted to days 21–40 of pregnancy, no stimulation was seen when LHRH was 
administered during days 45–50 of fertile cycle. In order to rule out the possibility that
the observed increase in CG is not due to interference in the mCG assay employed by 
pituitary LH released in response to LHRH, a control experiment was carried out. In 
this, non-pregnant cycling females were given 100 µg of LHRH on day 28 of cycle 
(corresponding to day 16 of pregnancy) and blood withdrawn at different times was 
 
 
Table 1. Efect of administration of low doses of LHRH
chronically on serum concentration of mCG in bonnet
monkeys. 
 
l0 µg of LHRH was injected by i.m. route every day from 
day 30 to day 36 of fertile cycle in 0·2 % gelatin,
n of each group is indicated by number in parenthesis.
* Not significantly different from control. 
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Figure 2. Efect of administration of 100 µg of LH RH 
by intravenous route to pregnant monkeys.
The stage of pregnancy in animals employed (n = 5) 
ranged from 21 to 40 days. Blood samples were collected 
prior to injection and at stipulated intervals following 
injection and serum mCG monitored by radioim- 
munoassay. Preinjection values were considered as 100% 
and any change following injection of LHRH expressed as 
percentage of preinjection value. 
 
 
 
 
analysed for mCG. Inclusion up to 300 µl of serum from these animals did not result in 
any interference in the mCG radioimmunoassay indicating the specificity of the assay 
employed. This essentially authenticated the results obtained with LHRH in pregnant 
monkeys. 
 
 
In vitro studies using human placental tissue 
 
As the placental tissue collected at MTP is generally contaminated with blood clots and 
uterine tissue, one of the first requirements before using the tissue for experiments was 
to establish the identity and functionality of the cells isolated from the tissue. This was 
ascertained by demonstrating the presence of hCG as judged by binding of [125I]- 
labelled antibody to intracellular hCG as well as precipitation of [3H]-leucine 
labelled/hCG synthesised by the cells. The data provided in table 2 shows that the 
cultured cells bound significant amount of [125I]-labelled hCG antibody over the 
 
Table 2. Localisation of hCG in cultured cells isolated 
from first trimester human placenta. 
 
Each value is Mean ± S.E.M. of 4 observations. 
* P <0·005.  
Cells were cultured for 15 days as described in methods. 
Medium removed, cells fixed with methanol-acetic acid (3:1) 
followed by saline wash. In Group I, plates were incubated in 
the presence of excess of unlabelled goat gamma globulin and 
[l25I]-labelled gamma globulin prepared from serum of 
goats immunised with hCG; while Group II was incubated 
only with [125I]-labelled anti hCG antibody.
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controls and the data presented in table 3 shows the synthesis of [3H]-leucine labeled 
hCG by the cells. Also the data presented in table 4 shows the viability of cells as judged 
by its ability to incorporate [3H]-leucine into protein and [3H]-thymidine into DNA.
 
Table 3. Demonstration of hCG synthesis by cells 
isolated from first trimester human placenta using short 
term incubation conditions.
 
Incubation was done at 37°C under 95 % oxygen and 5 % carbon dioxide  
for 6h in the presence of [3H]-leucine. Medium was processed for 
labelled hCG synthesised by addition of normal goat serum or goat 
antiserum to hCG. 
Each value is a Mean ± S.E.M. of 3 observations. 
* Ρ < 0·025. 
 
 
Table 4. Experiment to demonstrate the viability of 
placental cells isolated from first trimester human 
placenta. 
 
** Cells-incubated with excess of unlabelled leucine or thymidine. 
* P < 0·001 compared to corresponding control. 
Cells (1×106) were incubated at 37°C under 95% oxygen and 5%
carbon dioxide for 6 h. Medium was processed for protein and DNA.
 
 
Pattern of CG, progesterone and estradiol 17β secretion by cells in culture 
 
The data presented in figure 3 shows the pattern of CG, Ρ and Ε secretion into the 
medium over a period of 12 days. In agreement with other studies, Belleville et al. 
(1978), there is a rapid fall in the quantity of hCG, progesterone and estradiol 17 β 
secreted into the medium within first 48–96 h after which a steady state is maintained
indicating that the cells are in a viable state during experimental period.
 
Effect of addition of LHRH on CG, Ρ and Ε secretion into medium
 
In view of the recent demonstration that the placenta also produces LHRH like
material (Siler-Khodr and Khodr, 1978), it was of interest to examine the effects of
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Figure 3. Pattern of secretion of CG (A), progesterone (?) and estradiol 17β (Ο) (Β) by 
human placental cells in culture. 
Cells were isolated and cultured as described in methods. All points are Mean ± S.E.M. of 8 
observations. Values represent the quantity secreted during a 24 h period.
 
 
LHRH on CG secretion under in vitro conditions. Addition of LHRH (3·3 µg/ml) 
caused a significant increase in CG and estradiol 17β secreted into the medium (table 5). 
However, no effect was seen on progesterone concentration in medium. Thus the in 
vitro studies also provide additional evidence for the possible involvement of LHRH in 
stimulation of CG secretion.
 
 
Discussion 
 
The regulation of pituitary gonadotropin secretion by the modulation of the gonadal
steroids via LHRH is a well established fact. Functionally the placenta seem to exhibit 
characteristics of a composite hypothalamus, pituitary and gonad. In view of this it is 
quite justifiable to expect the placental function to be regulated by a similar mechanism. 
 
 
Table 5. Effect of addition of LHRH on hCG and estradiol 17 β secretion into 
culture medium by human placental cells.
 
Number of plates per group = 3. 
* P < 0·05 compared to value before addition. 
LHRH (3·3 µg/ml) was added per plate and 24 h later medium analysed for hCG and estradiol 17 β, by 
radioimmunoassay. 
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This is all the more to be expected for CG as this shares considerable structural and
functional homology with LH which is regulated by LHRH. However, our results show 
that while a negative regulation i.e., feed back inhibition by gonadal steroids does not 
seem to operate at the doses tried, LHRH seems to have a positive regulatory effect by 
stimulating CG production. The radioimmunoassay employed for monitoring CG 
values, has been validated for specificity using sera obtained from non-pregnant 
monkeys. The serum samples of LHRH injected non-pregnant monkeys have, as 
expected, been found to have increased serum LH as monitored by the mouse leydig cell 
assay (unpublished results). It should be pointed out that several studies have reported 
that CG is not detectable in pregnant rhesus monkeys beyond day 50–65 of fertile cycle 
(Hodgen, 1980). All the same Siler-Khodr (1979) report that administration of a 
relatively large dose of LHRH to pregnant rhesus monkeys on day 100 of gestation 
results in an increase in CG within 15 min. The present studies have been carried out 
using much lower dose of LHRH and monkeys at a stage of pregnancy when CG is 
normally secreted. 
In vitro studies using placental cell cultures have also shown that LHRH stimulates 
CG, and estradiol 17β secretion into medium. This is in agreement with the studies 
carried out by Ashitaka et al. (1980) and Siler-Khodr and Khodr (1981). In the present 
studies, analysis of hCG has been carried out by using an antiserum whose specificity 
towards a and β subunits was not fully established. Perhaps the use of a characterized
antisera to hCG would have provided more valuable information as the available 
studies on the cell-free synthesis of hCG indicates that the synthesis of β subunit is rate 
limiting (McQueen et al., 1978). Although our results suggest that LHRH stimulates 
CG secretion in placenta, it is not clear from these studies whether it stimulates 
synthesis of both subunits or only one of them or just the release. However, Ashitaka et 
al. (1980) report that while dibutyryl cyclic AMP stimulates only the release, LHRH 
may stimulate both production and secretion of hCG and its subunits. Studies of Currie 
et al. (1981) have also shown that there are specific receptors for LHRH in human 
placenta. Das and Talwar (1983) have shown that administration of LHRH agonist 
during early pregnancy resulted in termination of pregnancy in baboons. Our 
preliminary studies (unpublished observation) have shown that administration of 
antiserum to LHRH resulted in a decrease in serum CG levels. All the above cited 
evidences as well as the results described here clearly suggests that LHRH may be one of 
the important hormones involved in regulation of CG secretion. It has been suggested 
that LHRH is produced by the cytotrophoblast and acts on the syncytiotrophoblast 
which produces both steroids and peptide hormones. Thus while the pregnant monkey 
model described here provides a convenient way of assessing the activity of LHRH 
antagonists in vivo, the human placental system could perhaps be used for assessing 
quickly the in vitro activity of LHRH antagonists.
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